Euro RSCG Life LM&P Chicago Announces New Assignment from ImaRx

CHICAGO, Ill., Oct. 30 /PRNewswire/ -- Euro RSCG Life, a leading healthcare communications network, is proud to announce that their Chicago- based agency has been assigned agency-of-record responsibilities for ImaRx Therapeutics Inc. (ImaRx).

Euro RSCG Life LM&P Chicago will manage the re-branding of Abbokinase (urokinase), a thrombolytic approved and marketed for the treatment of acute massive pulmonary embolism. "It is very gratifying to see a company like ImaRx select Euro RSCG Life LM&P as their agency of record. This is, in fact, the seventh new brand assignment for the agency in the past twelve months and we are proud to be part of building brands for companies like ImaRx," said David Paragamian, President of Euro RSCG Life LM&P.

Skip Thurnauer, Managing Director of LM&P Chicago, will lead the agency's team. According to Thurnauer, "ImaRx is an interesting company with a commercially available product as well as innovative pipeline technology that positions them favorably to be a future player in the vascular disease and stroke markets. We are excited about the opportunity to work with them at this nascent stage of their development."

About Euro RSCG Life

Euro RSCG Life aligns the company's 44 health-focused offices in 22 countries. It creates a single network with almost 1,000 employees that offers clients comprehensive communications disciplines, including advertising, public relations, event promotion, medical education, interactive marketing and consulting services. The network's client roster includes GlaxoSmithKline, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough and Wyeth. Euro RSCG Life is part of Euro RSCG Worldwide, a leading integrated marketing communications agency that has been recognized as 2006 "Global Agency of the Year" by Advertising Age. Euro RSCG Worldwide is the largest unit of Havas, the world's fourth largest communications group.

About Euro RSCG Life LM&P

Euro RSCG Life LM&P Chicago is a full-service healthcare communications company particularly well-suited to work with emerging and smaller companies. The agency is a member of Euro RSCG Life, a network with 44 health-focused offices in 22 countries and almost 1,000 employees. Euro RSCG Life offers clients comprehensive communications disciplines, including advertising, public relations, event promotion, medical education, interactive marketing and consulting services. The network's client roster includes GlaxoSmithKline, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth. Euro RSCG Life is part of Euro RSCG Worldwide, a leading integrated marketing communications agency that has been recognized as 2006 "Global Agency of the Year" by Advertising Age. Euro RSCG Worldwide is the largest unit of Havas, the world's fourth largest communications group.

About ImaRx Therapeutics

ImaRx Therapeutics is a biopharmaceutical company developing and commercializing therapies for vascular disorders. The company's research and development efforts are focused on therapies for stroke and other vascular disorders using its proprietary microbubble technology. ImaRx Therapeutics' commercialization efforts are currently focused on its product, Abbokinase(R) for the treatment of acute massive pulmonary embolism.